|
Aug 1
|
Bausch Health Companies Second Quarter 2025 Earnings: Beats Expectations
|
|
Jul 31
|
TSX Flat at Midday With Healthcare, Energy, The Biggest Decliners
|
|
Jul 31
|
Bausch Health Stock Falls on Q2 Earnings Miss, Revenues Beat
|
|
Jul 31
|
Glaucoma Global Clinical Trials Market Landscape Report 2025 Featuring Alcon, AbbVie, Santen Pharmaceutical, Pfizer, Kowa, Viatris, Merck, Novartis, Senju Pharmaceutical, Bausch Health
|
|
Jul 31
|
Bausch Health Companies Inc (BHC) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...
|
|
Jul 31
|
Bausch (BHC) Reports Q2 Earnings: What Key Metrics Have to Say
|
|
Jul 31
|
Bausch Health (BHC) Lags Q2 Earnings Estimates
|
|
Jul 30
|
Bausch: Q2 Earnings Snapshot
|
|
Jul 30
|
Bausch Health Up 1.9% After Hours as Q2 Adjusted Income and Revenue Rise
|
|
Jul 30
|
Bausch Health Announces Second Quarter 2025 Results
|
|
Jul 29
|
Bausch Health to Acquire Nasdaq-listed Durect for US$63 Million
|
|
Jul 29
|
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
|
|
Jul 28
|
AllianceBernstein Global High Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE
|
|
Jul 28
|
Sector Update: Health Care Stocks Softer Monday Afternoon
|
|
Jul 28
|
Bausch Health to Reduce Debt by Approximately $900 Million Using Cash On Hand
|
|
Jul 24
|
Bausch Health Announces the Appointment of Two New Members to Its Board of Directors
|
|
Jul 15
|
Bausch Health's Xifaxan Patent Clarity, Policy Commentary in Focus for Q2, RBC Says
|
|
Jul 12
|
Bausch Health Companies (BHC) Canada Announces Expanded Availability of CABTREO Gel
|
|
Jul 11
|
Chlamydia Market Analysis and Forecast, 2025-2035 Featuring ActivBiotics, Bausch Health, Allergan, WCG Clinical, Hologic, Evofem, CRMI, Meridian Bioscience, Pfizer
|
|
Jul 2
|
Bausch Health to Announce Second Quarter 2025 Results on July 30
|